Chiropractors in Rogue River, OR Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Dr. Noah G. Jarvie, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 109 W Main St Unit 2, Rogue River, OR 97537 Phone: 541-582-6508 Fax: 541-582-6530 |
 Rogue River Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 109 W Main St Unit 2, Rogue River, OR 97537 Phone: 541-582-6508 Fax: 541-582-6530 |
Tlc Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 230 E Main St, Rogue River, OR 97537 Phone: 541-528-2323 Fax: 541-582-2419 |
Dr. Martin Dale Mcintosh, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 374 Covered Bridge Rd, Rogue River, OR 97537 Phone: 902-581-7497 Fax: 541-582-1972 |
Bryant L Kitchen, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 230 E Main St, Rogue River, OR 97537 Phone: 541-582-2323 Fax: 541-582-2419 |
Terrence L Clement Ii, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 230 E Main St, Rogue River, OR 97537 Phone: 541-582-2323 Fax: 541-582-2419 |
News Archive
Raw-type dog food contains high levels of multidrug-resistant bacteria
Microorganisms that infect animals, such as dogs, have the potential to jump to humans and cause illness. Zoonosis is a disease that can spread from animals to humans. These diseases pose health risks, mainly that some types can become life-threatening. Now, a study warns that raw-type dog food contains high levels of multidrug-resistant bacteria, which has the potential of transmitting the bacteria between dogs and humans.
Researchers advance stability of protein that may prevent brain damage from toxins
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility
Dendreon Corporation today announced that the U.S. Food and Drug Administration approved its Los Angeles cancer immunotherapy manufacturing facility, allowing the company to continue to increase the availability of PROVENGE across the U.S. to help meet the needs of patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.
Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis
Aradigm Corporation today announced positive top line data from its recently concluded Phase 2b study (Once-Daily Respiratory Bronchiectasis Inhalation Treatment - ORBIT-1) with Aradigm's ciprofloxacin for inhalation (CFI, ARD-3100, LipoquinTM) in patients with non-cystic fibrosis bronchiectasis (BE).
New definition for acute respiratory distress syndrome
Gordon D. Rubenfeld, M.D., of the Sunnybrook Health Sciences Center, Toronto, Canada, and colleagues with the ARDS (acute respiratory distress syndrome) Definition Task Force, developed a new definition of ARDS (the Berlin Definition) that focused on feasibility, reliability, validity and objective evaluation of its performance.
› Verified 2 days ago